Rifapentine
Clinical Indication
Treatment of latent tuberculosis, especially in patients with social exclusion and at high risk of noncompletion, or those with preexisting liver disease
Date of classification
February 2022
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.